|VENTURE FUNDING TOTAL||$2.98M|
|Series A, 9/11 ||$2.98M|
Atlanta Catheter Therapies, an early stage research and development medical device company, has a portfolio of innovative catheter technologies targeting vascular disease and restenosis. ACT is developing a revolutionary device for restenosis (re-blockage of blood vessels) and as well as catheters for endovascular debulking (clearing of blocked blood vessels).
The company was founded in 2008 by Dr. Rex Teeslink, M.D., an interventional radiologist, Dirk Hoyns, a medical device engineer, and the Medical Device Development Group (MDDG). Paul J. Fitzpatrick joined the team as CEO in January 2009.